|
|
ALS (Lou Gehrig's disease) |
 |
Additive Neuroprotective Effects of Creatine and Cyclooxygenase 2 Inhibitors in a Transgenic Mouse Model of ALS
Journal of Neurochemistry
This is an electronic version of an article published in the Journal of Neurochemistry: complete citation information for the final version of the paper, as published in the print edition of the Journal of Neurochemistry, is available on the Blackwell Synergy online delivery service, accessible via the journal's website at www.jneurochem.org or www.Blackwell-synergy.com |
|
Additive Neuroprotective Effects of minocycline with creatine in a mouse model of ALS
Annals of Neurology |
Huntington's Disease |
|
Creatine in Huntington's Disease is Safe, Tolerable, Bioavailable in Brain and Reduces Serum 8OH2'dG
Neurology
|
|
Creatine Therapy Provides Neuroprotection After Onset of Clinical Symptoms in HD Transgenic Mice
Journal of Neurochemistry
This is an electronic version of an article published in the Journal of Neurochemistry: complete citation information for the final version of the paper, as published in the print edition of the Journal of Neurochemistry, is available on the Blackwell Synergy online delivery service, accessible via the journal's website at www.jneurosci.org or www.Blackwell-synergy.com |
|
Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease
Journal of Neuroscience
This is an electronic version of an article published in the Journal of Neuroscience: complete citation information for the final version of the paper, as published in the print edition of the Journal of Neuroscience, is available on the Blackwell Synergy online delivery service, accessible via the journal's website at www.jneurosci.org or www.Blackwell-synergy.com |
Parkinson's Disease |
|
A Randomized, Double-Blinded Futility Clinical Trial of Creatine and Minocycline in Early Parkinson’s Disease
Neurology
|
|
Additive Neuroprotective Effects of Creatine and a Cyclooxygenase 2 Inhibitor Against Dopamine Depletion in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease
Journal of Molecular Neuroscience
This article, which appeared in Volume 21, 2003 of the Journal of Molecular Neuroscience, is reprinted with the permission of Humana Press |
Charcot-Marie Tooth Syndrome |
|
Resistance training exercise and creatine in patients with Charcot-Marie-Tooth
Muscle & Nerve |
|
Creatine Therapy Provides Neuroprotection After Onset of Clinical Symptoms in HD Transgenic Mice
Journal of Neurochemistry
This is an electronic version of an article published in the Journal of Neurochemistry: complete citation information for the final version of the paper, as published in the print edition of the Journal of Neurochemistry, is available on the Blackwell Synergy online delivery service, accessible via the journal's website at www.jneurochem.org or www.Blackwell-synergy.com |
|
|
| |
|
